An atlas of healthy and injured cell states and niches in the human kidney
…, N Plongthongkum, A Knoten, S Urata, LH Mariani… - Nature, 2023 - nature.com
Understanding kidney disease relies on defining the complexity of cell types and states, their
associated molecular profiles and interactions within tissue neighbourhoods 1 . Here we …
associated molecular profiles and interactions within tissue neighbourhoods 1 . Here we …
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker
Chronic kidney disease (CKD) affects 8 to 16% people worldwide, with an increasing incidence
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …
and prevalence of end-stage kidney disease (ESKD). The effective management of CKD …
The renal manifestations of thyroid disease
LH Mariani, JS Berns - Journal of the American Society of …, 2012 - journals.lww.com
Thyroid hormones influence renal development, kidney structure, renal hemodynamics, GFR,
the function of many transport systems along the nephron, and sodium and water …
the function of many transport systems along the nephron, and sodium and water …
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis
…, LH Mariani, MJ Somers, H Trachtman… - American Journal of …, 2013 - Elsevier
Glomerulonephritis (GN) is an important cause of morbidity and mortality in patients of all
ages throughout the world. Because these disorders are relatively rare, it is difficult to perform …
ages throughout the world. Because these disorders are relatively rare, it is difficult to perform …
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
…, S Sanna-Cherchi, MG Sampson, LH Mariani… - Nature …, 2020 - nature.com
Membranous Nephropathy (MN) is a rare autoimmune cause of kidney failure. Here we
report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 …
report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 …
Rationale and design of the kidney precision medicine project
…, R Knight, ZG Laszik, C Lienczewski, LH Mariani… - Kidney international, 2021 - Elsevier
Chronic kidney disease (CKD) and acute kidney injury (AKI) are common, heterogeneous,
and morbid diseases. Mechanistic characterization of CKD and AKI in patients may facilitate a …
and morbid diseases. Mechanistic characterization of CKD and AKI in patients may facilitate a …
Integrated multi-omics approaches to improve classification of chronic kidney disease
S Eddy, LH Mariani, M Kretzler - Nature Reviews Nephrology, 2020 - nature.com
Chronic kidney diseases (CKDs) are currently classified according to their clinical features,
associated comorbidities and pattern of injury on biopsy. Even within a given classification, …
associated comorbidities and pattern of injury on biopsy. Even within a given classification, …
[PDF][PDF] Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight
…, RJW Li, DR Barros, R Kuah, YM Lim, LH Mariani… - Cell Metabolism, 2023 - cell.com
Metformin, the most widely prescribed medication for obesity-associated type 2 diabetes (T2D),
lowers plasma glucose levels, food intake, and body weight in rodents and humans, but …
lowers plasma glucose levels, food intake, and body weight in rodents and humans, but …
[HTML][HTML] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
JM Spinale, LH Mariani, S Kapoor, J Zhang… - Kidney international, 2015 - Elsevier
It has been suggested that soluble urokinase receptor (suPAR) is a causative circulating
factor for and a biomarker of focal and segmental glomerulosclerosis (FSGS). Here we …
factor for and a biomarker of focal and segmental glomerulosclerosis (FSGS). Here we …
Integrative genomics identifies novel associations with APOL1 risk genotypes in black NEPTUNE subjects
…, CC Robertson, S Martini, LH Mariani… - Journal of the …, 2016 - journals.lww.com
APOL1 variants have been associated with renal phenotypes in blacks. To refine clinical
outcomes and discover mechanisms of APOL1-associated kidney injury, we analyzed clinical …
outcomes and discover mechanisms of APOL1-associated kidney injury, we analyzed clinical …